Edesa Biotech (EDSA) Misses Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts EDSA Hot Sheet
Join SI Premium – FREE
Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.30).
For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
- OpenAI and Meta warn U.S. judicial panel about deepfake evidence
- Cameco Corp. (CCJ) spreader of 26486 contracts of October 80 puts and 10906 contracts of November 90 puts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
